Phase II study of tepotinib + gefitinib (TEP+GEF) in MET-positive (MET+)/epidermal growth factor receptor (EGFR)-mutant (MT) non-small cell lung cancer (NSCLC)

Annals of Oncology ◽

10.1093/annonc/mdy292 ◽

2018 ◽

Vol 29 ◽

pp. viii493 ◽

Author(s):

Y. Cheng ◽

J. Zhou ◽

S. Lu ◽

Y. Zhang ◽

J. Zhao ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase Ii Study ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Download Full-text

Atezolizumab and Bevacizumab in Epidermal Growth Factor Receptor (EGFR) Mutant Non‐Small Cell Lung Cancer in Patients With Progressive Disease After Receiving Osimertinib

Case Medical Research ◽

10.31525/ct1-nct04099836 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progressive Disease ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Download Full-text

P3-128: Correlation of the epidermal growth factor receptor mutations with clinical outcomes in patients with non–small cell lung cancer treated gefitinib: an exploratory molecular analysis of a prospective phase II study

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000284103.12311.8d ◽

2007 ◽

Vol 2 (8) ◽

pp. S733-S734

Author(s):

Hyewon Lee ◽

Hoyong Sim ◽

Se Hoon Park ◽

Jinny Park ◽

Eun Kyung Cho ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase Ii Study ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Prospective Phase ◽

Epidermal Growth

Download Full-text

Therapeutic options for advanced epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer: a Bayesian network secondary analysis

Aging ◽

10.18632/aging.103066 ◽

2020 ◽

Vol 12 (8) ◽

pp. 7129-7162

Author(s):

Xinmin Zeng ◽

Xuan Wan ◽

Jun Xu ◽

Hui Wang ◽

Hua Chen ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Secondary Analysis ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Download Full-text

Phase II study of erlotinib in elderly patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-015-2784-x ◽

2015 ◽

Vol 76 (1) ◽

pp. 155-161 ◽

Author(s):

Yusuke Inoue ◽

Naoki Inui ◽

Kazuhiro Asada ◽

Masato Karayama ◽

Hiroyuki Matsuda ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Elderly Patients ◽

Phase Ii Study ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth

Download Full-text

A phase II study of gefitinib in combination with S-1 plus carboplatin as first-line triplet chemotherapy for patients with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e19095 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e19095-e19095

Author(s):

Akihiro Tamiya ◽

Motohiro Tamiya ◽

Takeshi Nakatani ◽

Takayuki Shiroyama ◽

Kanako Kitai ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase Ii Study ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth

Download Full-text

A phase II study of Erbitux (IMC-C225), an Epidermal Growth Factor Receptor (EGFR) blocking ntibody, in combination with docetaxel in chemotherapy refractory/resistant patients with advanced Non-Small Cell Lung Cancer (NSCLC)

European Journal of Cancer ◽

10.1016/s0959-8049(02)81165-0 ◽

2002 ◽

Vol 38 ◽

pp. S153 ◽

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth

Download Full-text

Phase II Study Of Erlotinib As Third-Line Monotherapy In Patients With Advanced Non-Small-Cell Lung Cancer Without Epidermal Growth Factor Receptor Mutations

10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4408 ◽

2012 ◽

Author(s):

Shun Matsuura ◽

Naoki Inui ◽

Yuichi Ozawa ◽

Toshihiro Shirai ◽

Mikio Toyoshima ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase Ii Study ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Download Full-text

Phase II Study of Erlotinib as Third-line Monotherapy in Patients with Advanced Non-small-cell Lung Cancer without Epidermal Growth Factor Receptor Mutations

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyr079 ◽

2011 ◽

Vol 41 (8) ◽

pp. 959-963 ◽

Author(s):

S. Matsuura ◽

N. Inui ◽

Y. Ozawa ◽

Y. Nakamura ◽

M. Toyoshima ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase Ii Study ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Download Full-text

Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease.

Case Medical Research ◽

10.31525/ct1-nct03994393 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Cancer Trial ◽

Epidermal Growth ◽

Download Full-text

The role of osimertinib in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer

Journal of Thoracic Disease ◽

10.21037/jtd.2018.11.45 ◽

2019 ◽

Vol 11 (S3) ◽

pp. S448-S452

Author(s):

Chong-Kin Liam

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Download Full-text